Validations: Intended Use, Data Readiness & Bias

Annotation Playbooks: SOPs and Quality Gates Annotation Playbooks: SOPs and Quality Gates in AI/ML Model Validation Introduction to AI/ML Model Validation The integration of artificial intelligence (AI) and machine learning (ML) models into Good Practice (GxP) environments has revolutionized the pharmaceutical industry. Regulatory authorities such as the FDA, EMA, and MHRA emphasize the importance of rigorous validation frameworks to ensure…

Synthetic Data in Regulated Analytics: When and How Introduction to Synthetic Data in Regulated Analytics The use of artificial intelligence (AI) and machine learning (ML) is becoming increasingly prevalent in the pharmaceutical sector, particularly in regulated analytics. As the industry trends towards these advanced technologies, understanding the context in which synthetic data can be utilized becomes essential. This tutorial will…

Data Provenance: ETL/ELT Lineage and Evidence Data Provenance: ETL/ELT Lineage and Evidence Introduction to AI/ML Model Validation in GxP Analytics In the landscape of pharmaceutical development and production, the integration of artificial intelligence (AI) and machine learning (ML) represents a transformative approach to data handling and analysis. Validation of these AI/ML models ensures compliance with Good Practice (GxP) regulations and…

PII/PHI Considerations in Training Sets PII/PHI Considerations in Training Sets: A Step-by-Step Guide Introduction to AI/ML Model Validation in GxP Analytics Artificial Intelligence (AI) and Machine Learning (ML) have become increasingly integral to pharmaceutical analytics, particularly in Good Automated Manufacturing Practice (GxP) environments. The validation of AI/ML models within this realm is crucial not only for compliance with regulatory guidelines…

Reference Architectures for Data Pipelines in GxP Understanding GxP and Its Applications in AI/ML Model Validation The Good Practice (GxP) guidelines are essential for ensuring that pharmaceutical and biopharmaceutical products are consistently produced and controlled according to quality standards. Within the realm of AI and ML, model validation and its regulatory requirements have gradually evolved to keep pace with technological…

Reference Architectures for Data Pipelines in GxP Reference Architectures for Data Pipelines in GxP: A Step-by-Step Tutorial Guide Introduction to AI/ML Model Validation in GxP Analytics Artificial Intelligence (AI) and Machine Learning (ML) technologies are increasingly being adopted in the pharmaceutical sector, leading to enhanced analytical capabilities and operational efficiencies. However, leveraging these technologies within Good Practice (GxP) frameworks introduces…

Data Quality KPIs for AI Workstreams Understanding AI/ML Model Validation Artificial Intelligence (AI) and Machine Learning (ML) are fast becoming integral components in the pharmaceutical industry’s analytics practices, particularly in GxP environments. It is vital to ensure that AI/ML systems are validated effectively to meet the rigorous standards required by regulatory bodies like the FDA, EMA, and MHRA. This means…

Data Quality KPIs for AI Workstreams Data Quality KPIs for AI Workstreams Introduction to AI/ML Model Validation in GxP Analytics The rapid adoption of artificial intelligence (AI) and machine learning (ML) in the pharmaceutical sector has introduced both opportunities and challenges in ensuring compliance with Good Automated Manufacturing Practice (GxP) standards. Proper AI/ML model validation is crucial in maintaining data…

Sampling Strategies: Stratified, Time-Based, and Risk-Based Sampling Strategies: Stratified, Time-Based, and Risk-Based Understanding AI/ML Model Validation in GxP Analytics The pharmaceutical industry is increasingly leveraging Artificial Intelligence (AI) and Machine Learning (ML) technologies to enhance drug development, improve operational efficiencies, and ensure compliance with regulatory standards. However, the validation of AI/ML models, particularly in a Good Practice (GxP) context, requires…

Sampling Strategies: Stratified, Time-Based, and Risk-Based Sampling Strategies: Stratified, Time-Based, and Risk-Based In the rapidly evolving domain of AI/ML within Good Practice (GxP) analytics, robust validation methodologies are essential for ensuring compliance with regulatory requirements, particularly concerning intended use risk, data readiness curation, and bias and fairness testing. As organizations strive to implement effective ai ml model validation processes, sampling…